3302 NEW ZEALAND GAZETTE, No. 127 14 AUGUST 2008

pharmacy-only medicines. As such, they are now available for general sale.

Aspirin; except when specified in the First Schedule to the Medicines Regulations 1984

Benzydamine; for dermal use

Choline salicylate; in medicines containing 10% or less and in pack sizes of 15 grams or less

Boron including borax and boric acid; in medicines for internal use containing 6 milligrams or less per recommended daily dose; for dermal use other than paediatric use in medicines containing 0.35% or less; when present as an excipient

Etidronic acid; in medicines for external use containing 1% or less

Liquorice; deglycyrrhizinised

Lithium; for dermal use in medicines containing 0.01% or less; when present as an excipient in medicines for dermal use containing 0.25% or less

Lobeline; in medicines for smoking or burning

Methyl salicylate; for external use; for internal use when present as an excipient in medicines containing 1.04% or less per dose form

Nicotinamide

Nicotinic acid; in medicines containing 100 milligrams or less per dose form

Octocog alfa

Oxiconazole; for dermal use in medicines for tinea pedis only

Perflutren

Polysulfated glycosaminoglycans; except in injections other than intraocular viscoelastic products

Pyrethrins; in medicines containing 10% or less

Pyridoxal; in medicines containing 200 milligrams or less per recommended daily dose

Pyridoxamine; in medicines containing 200 milligrams or less per recommended daily dose

Pyrithione zinc; for treatment of the scalp in medicines containing 2% or less

*Ranitidine; in medicines containing not more than 150 milligrams per dose unit which have received the consent of the Minister or the Director-General to their distribution as general sale medicines and which are sold in the manufacturer’s original pack containing not more than 7 day’s supply

Salicylic acid; in medicines containing 40% or less

Selenium; for oral use in medicines containing 150 micrograms or less per recommended daily dose; for external use in medicines containing 3.5% or less of selenium sulfide

Vitamin A; for internal use in medicines containing 3000 micrograms or less of retinol equivalents per recommended daily dose; in parenteral nutrition replacement preparations; for external use in medicines containing 1% or less

Vitamin D; for external use; for internal use in medicines containing 25 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations

*Zinc; for external use except in medicines containing more than 5% of zinc chloride; for internal use in medicines containing 25 milligrams or less per recommended daily dose; for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs which have received the consent of the Minister or the Director-General to their distribution as general sale medicines and which are sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; in parenteral nutrition replacement preparations

*Regulation 20 of the Medicines Regulations 1984 requires that all medicines sold without a practitioner’s prescription must include a consumer information panel on the label. Further, all material changes to a medicine (including changes to labelling) must be notified to the Director-General of Health in accordance with section 24 of the Medicines Act 1981.

Dated this 7th day of August 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate.

go5888

New Zealand Public Health and Disability Act 2000

Inaugural Appointments to the Family Violence Death Review Committee

Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I appoint to the Family Violence Death Review Committee

Wendy Davis
as chairperson for a three-year term of office commencing from the date of this notice; and

Dr Patrick Kelly
Dr Alison Towns
as members for three-year terms of office commencing from the date of this notice; and

Ngaroma Grant
Rob Veale
Vaoga Mary Watts
as members for two-year terms of office commencing from the date of this notice; and

Brenda Hynes
George Ririnui
as members for one-year terms of office commencing from the date of this notice.

Dated at Wellington this 6th day of August 2008.

HON STEVE CHADWICK, Associate Minister of Health.

go5795

Appointment to the Tairawhiti District Health Board

Pursuant to section 29(1)(b) of the New Zealand Public Health and Disability Act 2000, and notice given under section 28(2) of the Crown Entities Act 2004 (“the Act”), I have appointed

Bevan William Turnpenny
as a member, under section 28(1)(a) of the Act, to the Tairawhiti District Health Board.

This appointment takes effect on 11 August 2008 and will end on 5 December 2010.

Dated at Wellington this 5th day of August 2008.

HON STEVE CHADWICK, Associate Minister of Health.

go5758